(Q46433672)

22 December 2017

title

Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects (English)

1 reference

22 December 2017

1 reference

6

Vincent Soriano

1 reference

22 December 2017

Sonia Rodriguez-Novoa

1

1 reference

22 December 2017

Pablo Barreiro

2

1 reference

22 December 2017

Ana Rendón

3

1 reference

22 December 2017

Inmaculada Jiménez-Nacher

4

1 reference

22 December 2017

Juan González-Lahoz

5

1 reference

22 December 2017

language of work or name

English

0 references

publication date

31 March 2005

1 reference

22 December 2017

Clinical Infectious Diseases

published in

1 reference

22 December 2017

volume

40

1 reference

22 December 2017

page(s)

1358-1361

1 reference

22 December 2017

issue

9

1 reference

22 December 2017

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

cites work

1 reference

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

21 January 2018

1 reference

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz

21 January 2018

1 reference

Gender difference in ifosfamide metabolism by human liver microsomes

21 January 2018

1 reference

Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans

21 January 2018

1 reference

The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity

21 January 2018

1 reference

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

21 January 2018

1 reference

Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography.

21 January 2018

1 reference

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

21 January 2018

1 reference

Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/429327

1 reference

22 December 2017

PubMed ID

15825040

1 reference

22 December 2017